Researchers examined the association between micronutrient intake and the risk for ulcerative colitis.
Using a symptom tracker app, researchers assessed the risk for long COVID among patients infected with the Delta or the Omicron variant between 2 time periods.
The APOLLO-B study included patients 18 years of age and older with ATTR amyloidosis (hereditary or wild-type) with cardiomyopathy.
NexoBrid is a topically administered, bromelain-based biological product containing a sterile mixture of proteolytic enzymes.
Rebinyn is a recombinant DNA-derived coagulation Factor IX concentrate with an extended half-life.
The FDA has approved Kyzatrex (testosterone undecanoate) for the treatment of primary and secondary hypogonadism in adult males.
Panel recommends counseling all women aged 40 to 60 years on healthy eating and physical activity to maintain weight or prevent weight gain.
Ines Moreno-Gonzalez, PhD, an adjunct associate professor of neurology, explains healthy aging can help reduce lifestyle risk factors for Alzheimer disease.
KP104 is a bifunctional, first-in-class biologic that works by selectively inhibiting the alternative and terminal pathways in the complement system.
The application is supported by data from the two phase 3 induction studies, U-EXCEED and U-EXCEL, and one phase 3 maintenance study, U-ENDURE.
To address the ongoing COVID-19 related iodinated contrast media product shortage, Iomeron will be temporarily available in the US starting at the end of August 2022.
Immunocompromised individuals may be at an increased risk for invasive infections if a contaminated product is consumed.
An individual is considered fully vaccinated about 2 weeks after the second dose of Jynneos and 4 weeks after receiving ACAM2000.
The Simplist ready-to-administer prefilled syringes minimize preparation steps for clinicians.
The designation was based on data from two phase 2 proof-of-concept studies that evaluated VX-548 for acute pain following abdominoplasty or bunionectomy surgery.
The application is under review for relapsing forms of multiple sclerosis and Crohn disease.
Researchers assessed the safety and efficacy of the QazCovid-in COVID-19 vaccine.
Patients received PH94B or placebo intranasally 20 minutes before an induced public speaking challenge to relieve symptoms of anxiety.
What factors influence the effectiveness of COVID-19 vaccination with inactivated virus? Two studies of Indonesian health care workers explored this question.
The sBLA is supported by data from a phase 1 pharmacokinetics bridging study comparing Hyrimoz 50mg/mL and citrate-free Hyrimoz HCF.